Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls

Platelet Antisedimentation Rate and Multiplate ex Vivo Examinations in Cerebrovascular Patients Treated With Antiplatelet Therapy and Healthy Controls

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03679858

Enrollment

100

Registered

2018-09-20

Start date

2018-01-01

Completion date

2019-01-01

Last updated

2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Disorders, Platelet Refractoriness, Platelet Aggregation, Spontaneous

Brief summary

To search for simple laboratory methods selecting patients with low/non-responsiveness to P2Y12 receptor antagonists.

Interventions

OTHERPlatelet function test

Ex vivo platelet aggregation analysis by Multiplate aggregometer

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Written informed consent

Exclusion criteria

* Declined informed consent

Design outcomes

Primary

Measure	Time frame
Major cerebrovascular event	1 year

Countries

Hungary

Contacts

Primary ContactTihamer Molnar, MD, PhD

tihamermolnar@yahoo.com+36302275814

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026